"Substantial" hospital burden for varicella herpes zoster in England Clinical study 02 July 2016 Pages: 7 - 7
Acthar costs similar to PMP or IVIG in MS with multiple relapses Clinical study 02 July 2016 Pages: 8 - 8
Active surveillance cost effective for first-line HAART in Namibia Clinical study 02 July 2016 Pages: 9 - 9
Bevacizumab not cost effective for advanced ovarian cancer Clinical study 02 July 2016 Pages: 12 - 12
Breast cancer screening in UK cost effective up to 78 years Clinical study 02 July 2016 Pages: 13 - 13
Chondrocyte implantation cost effective for cartilage defects Clinical study 02 July 2016 Pages: 14 - 14
Diagnostic-driven antifungal strategy cost saving in China Clinical study 02 July 2016 Pages: 19 - 19
End-of-life expenditure higher with multiple chronic disorders Clinical study 02 July 2016 Pages: 20 - 20
Eplerenone cost effective for mild heart failure in Canada Clinical study 02 July 2016 Pages: 21 - 21
ICERs higher in Markov model for MS using alternatives to EQ-5D Clinical study 02 July 2016 Pages: 24 - 24
MT-sDNA test not cost effective for colorectal cancer screening Clinical study 02 July 2016 Pages: 25 - 25
Obinutuzumab plus chlorambucil cost effective in untreated CLL Clinical study 02 July 2016 Pages: 26 - 26
Routine use of bevacizumab for cervical cancer not sustainable Clinical study 02 July 2016 Pages: 28 - 28
Syringe dead-space leads to costs due to medication wastage Clinical study 02 July 2016 Pages: 32 - 32
Timing of IV PPI treatment has modest effect on total cost Clinical study 02 July 2016 Pages: 33 - 33
Transdermal buprenorphine for OA pain increases satisfaction Clinical study 02 July 2016 Pages: 34 - 34
Zoledronic acid and Sr89 cost effective in prostate cancer Clinical study 02 July 2016 Pages: 36 - 36